![]() |
||
Press ReleasesMary Ellen Zipper, Director of Client Relations, to offer advice for successful PHR implementation through case study findings for both patients and consumers NEWTOWN, PA, May 16, 2008-- CapMed, a division of Bio-Imaging Technologies, Inc. (NASDAQ: BITI) and a leader in interactive personal health management solutions, today announced that Mary Ellen Zipper, Director of Client Relations, will educate attendees about the “Key to Personal Health Record Adoption” at this year’s TEPR conference in “Educating both hospital staff and patients on the basics of PHR use and maintenance as well as its many benefits is essential for successful PHR adoption,” says Zipper. “Once educated, patients gain a valuable skill set for personal health management resulting in overall increased self-knowledge of their own health, while caregivers can begin to take the necessary steps needed to streamline their work and devote more time to providing quality care.” CapMed is leading the way in PHR adoption, recognizing that ongoing education is needed in persuading patients to adopt and maintain a PHR. Zipper will be presenting a case study, highlighting a particular hospital’s success in rolling out a PHR program by effectively influencing patients to develop personal health records and educating them on how to maintain their newly-adopted technology. Points of interest to be addressed include easy-to-learn terms, hypothetical scenarios, learning sessions, and hands-on training along with how to give guidance on maintaining copies of medical records. Despite the benefits and proposed incentives for ongoing PHR usage, widespread consumer adoption of PHRs will follow the availability of standardized electronic information that is easily imported and exported. Because only 20 percent of physicians are utilizing EMRs in their practice of medicine, 80 percent of physicians cannot help their patients easily populate and maintain a comprehensive PHR which is why education on this subject matter is imperative within the healthcare industry. The TEPR Conference includes more than 500 speakers, close to 5,000 attendees, and approximately 200 exhibitors. While at TEPR, CapMed will showcase its interoperability with other exhibitors. CapMed will reveal how providers and consumers can easily populate these records with lab results, radiology images, medical summaries, referrals, home monitoring device data and cardiology reports. Stop by CapMed’s booth #429 to learn more about this exciting demonstration. About CapMed CapMed, a division of Bio-Imaging Technologies, Inc., is the cornerstone of Bio-Imaging’s Personal Health Management Division. CapMed is the leading provider of personal health management solutions for hospitals and health systems, providers, managed care, employers, and pharmaceutical companies, with more than 600,000 distributed to date. These solutions enable patients to monitor and manage their health and to improve communications with care providers, ultimately improving outcomes and reducing costs of care and are available in multiple formats: onlinePHR, icePHR, icePHR Bio-Imaging Technologies, Inc Bio-Imaging Technologies, Inc. is a healthcare contract service organization providing services that support the product development process of the pharmaceutical, biotechnology and medical device industries. The Company has specialized in assisting its clients in the design and management of the medical-imaging component of clinical trials since 1990. Bio Imaging serves its clients on a global basis through its Core Labs in Certain matters discussed in this press release are “forward-looking statements” intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company’s statements regarding trends in the marketplace and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the consummation and the successful integration of current and proposed acquisitions, the timing of projects due to the variability in size, scope and duration of projects, estimates and guidance made by management with respect to the Company’s financial results, backlog, critical accounting policies, regulatory delays, clinical study results which lead to reductions or cancellations of projects, and other factors, including general economic conditions and regulatory developments, not within the Company’s control. The factors discussed herein and expressed from time to time in the Company’s filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed in or implied by such statements. The forward-looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstance. You should review the Company’s filings, especially risk factors contained in the Form 10-K and the recent form 10-Q. |
Related Resources |
|
Home | Support |Contact Us | For Individuals | Privacy Policy | Terms & Conditions CapMed: 1-877-CapMed6 (1-877-227-6336) Copyright ©2005 CapMed. All Rights Reserved. |